Citi Upgrades Merus N.V. (MRUS) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Incyte and Merus Announce Global Strategic Research Collaboration to Discover and Develop Bispecific Antibodies
December 21, 2016 7:00 AM ESTCollaboration designed to leverage Merus Biclonics® bispecific antibody technology to expand Incytes discovery capabilities and large-molecule portfolio Incyte to make up-front payment of $120 million and purchase $80 million of Merus common shares; Merus eligible to receive potential development, regulatory and commercial milestones and sales royalties Merus conference call scheduled today at 8:30 a.m. ET, 2:30 p.m. CET
WILMINGTON, Del. & UTRECHT, Netherlands--(BUSINESS WIRE)-- Incyte Corporation (NASDAQ: INCY) and Merus N.V. (NASDAQ: MRUS) announced... More



